INBX
Inhibrx
--
--(--)
Market Open: --
--
--(--)
Post-Market: --
INBX Profile
Inhibrx Biosciences, Inc.
A biotechnology company committed to researching and developing new biological agents for the treatment of various diseases.
11025 N. Torrey Pines Road, Suite 140 La Jolla, California 92037
--
Inhibrx Biosciences, Inc., was incorporated under the laws of the State of Delaware on January 8, 2024 and is a direct, wholly owned subsidiary of Inhibrx, Inc. The Company is a clinical-stage biopharmaceutical company with a portfolio of novel biotherapeutic drug candidates developed using its proprietary modular protein engineering platform.